1887

Abstract

Summary

A recently described autoantibody-inducing agent in mice was further characterized. Tentatively designated AGIA (anti-Golgi apparatus-inducing agent), this agent has previously been shown to cause antibody production against Golgi apparatus (GA) antigen of cells from different vertebrate species as well as against tumour surface antigen of the Moloney murine sarcoma virus-non-producer transformant Sac. It was shown to possess the properties characteristic of lactate dehydrogenase-elevating virus (LDV). It induced elevation of lactate dehydrogenase levels in the blood, persistent lifelong viraemia in mice and serum titres of up to 10 infectious doses (ID) per ml in the acute phase of infection. Its replication was limited to subpopulations of murine peritoneal macrophages. Electron microscopy of AGIA-infected macrophages and of serum of infected mice revealed virus-like particles with a morphology resembling LDV. The buoyant density of AGIA was approximately 1·14 g/ml. Both the enzyme-elevating activity and the autoantibody-inducing activity were shown to belong to LDV. Infection of STU mice with two established strains of LDV (LDV and LDV) was also found to induce both autoantibody groups. In both cases, after infection with AGIA as well as after infection with the two known LDV isolates, anti- Sac cell antibodies occurred at comparable titres. However, anti-GA antibody titres were rather low after infection with LDV and LDV compared with AGIA infection. Serological cross-reactivity was demonstrated between AGIA-, LDV-and LDV-infected macrophages. AGIA induced anti-GA antibodies in all six mouse strains tested (STU, DBA/2, BALB/c, C3H/He, NMRI, C57BL/6); however, anti-Sac cell antibodies did not develop in C57BL/6 mice.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-68-7-1983
1987-07-01
2022-08-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/68/7/JV0680071983.html?itemId=/content/journal/jgv/10.1099/0022-1317-68-7-1983&mimeType=html&fmt=ahah

References

  1. Brinton-Darnell M., Plagemann P. G. W. 1975; Structure and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. Journal of Virology 16:420–433
    [Google Scholar]
  2. Cafruny W. A., Plagemann P. G. W. 1982a; Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus. Infection and Immunity 37:1007–1012
    [Google Scholar]
  3. Cafruny W. A., Plagemann P. G. W. 1982b; Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Infection and Immunity 37:1001–1006
    [Google Scholar]
  4. Coutelier J. P., Van Snick J. 1985; Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. European Journal of Immunology 15:250–255
    [Google Scholar]
  5. Crispens C. G. 1982; Detection and characterization of a lymphocyte proliferating factor (LPF) in plasma of SJL/J mice infected with LDH virus. Archives of Virology 72:67–74
    [Google Scholar]
  6. Fritzler M. J., Etherington J., Sokoluk C., Kinsella T. D., Valencia D. W. 1984; Antibodies from patients with autoimmune disease react with a cytoplasmic antigen in the Golgi apparatus. Journal of Immunology 132:2904–2908
    [Google Scholar]
  7. Horzinek M. C. 1981; Non-arthropod-bome togaviruses. In Experimental Virology pp. 1–200 Tinsley T. W., Brown F. Edited by London & New York: Academic Press;
    [Google Scholar]
  8. Horzinek M. C., Van Wielink P. s., Ellens D. J. 1975; Purification and electron microscopy of lactic dehydrogenase virus of mice. Journal of General Virology 26:217–226
    [Google Scholar]
  9. Inada T., Mims C. A. 1984; Mouse la antigens are receptors for lactate dehydrogenase virus. Nature; London: 30959–61
    [Google Scholar]
  10. Inada T., Mims C. A. 1986; Live lactate dehydrogenase-elevating virus (LDV) induces suppressor T cells that inhibit the development of delayed hypersensitivity to LDV. Journal of General Virology 67:2103–2112
    [Google Scholar]
  11. Martinez D., Brinton M. A., Tachovsky T. G., Phelps A. H. 1980; Identification of lactate dehydrogenase-elevating virus as the etiological agent of genetically restricted, age-dependent polio-encephalomyelitis of mice. Infection and Immunity 27:979–987
    [Google Scholar]
  12. Mathews M. B., Bernstein R. M. 1983; Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature; London: 304177–179
    [Google Scholar]
  13. Michaelides M. C., Simms E. S. 1977; Immune response in mice infected with lactic dehydrogenase virus. I.Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice. Immunology 32:981–988
    [Google Scholar]
  14. Michaelides M. C., Simms E. S. 1980; Immune response in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Cellular Immunology 50:253–260
    [Google Scholar]
  15. Nawrocki J. F., Pease L. R., Murphy W. H. 1980; Etiologic role of lactic dehydrogenase virus infection in an age-dependent neuroparalytic disease in C58 mice. Virology 103:259–264
    [Google Scholar]
  16. Notkins A. L. 1965; Lactic dehydrogenase virus. Bacteriological Reviews 29:143–160
    [Google Scholar]
  17. Notkins A. L., Mahar S., Scheele C., Goffman J. 1966; Infectious virus-antibody complex in the blood of chronically infected mice. Journal of Experimental Medicine 124:81–97
    [Google Scholar]
  18. Notkins A. L., Onodera T., Prabhakar B. S. 1984; Virus-induced autoimmunity. In Concepts in Viral Pathogenesis pp. 210–215 Notkins A. L., Oldstone M. B. A. Edited by New York, Berlin, Heidelberg & Tokyo: Springer-Verlag;
    [Google Scholar]
  19. Onodera T., Toniolo A., Ray U. R., Jenson A. B., Knazek R. A., Notkins A. L. 1981; VlrUS-induCed diabetes mellitus XX. Polyendocrinopathy and autoimmunity. Journal of Experimental Medicine 153:1457–1473
    [Google Scholar]
  20. Pfreundschuh M., Shiku H., Takahashi T., Ueda R., Ransohoff J., Oettgen H. F., Old L. J. 1978; Serological analysis of cell surface antigens of malignant human brain tumours. Proceedings of the National Academy of Sciences, U.S.A 75:5122–5126
    [Google Scholar]
  21. Riley V. 1968; Lactate dehydrogenase in the normal and malignant state in mice and the influence of a benign enzyme-elevating virus. In Methods in Cancer Research 4 pp. 493–618 Busch H. Edited by London: Academic Press;
    [Google Scholar]
  22. Riley V., Lilly F., Huerto E., Bardell D. 1960; Transmissible agent associated with 26 types of experimental mouse neoplasms. Science 132:545–547
    [Google Scholar]
  23. Rodriguez J. L., Gelpi C., Thompson T. M., Real F. J., Fernandez J. 1982; Anti-Golgi Complex autoantibodies in a patient with Sjogren’s syndrome and lymphoma. Clinical and Experimental Immunology 49:579–586
    [Google Scholar]
  24. Rowson K. E. K., Mahy B. W. J. 1975; Lactic dehydrogenase virus. Virology Monographs 13 pp. 1–121 Vienna & New York: Springer-Verlag;
    [Google Scholar]
  25. Rowson K. E. K., Mahy B. W. J. 1985; Lactate dehydrogenase-elevating virus. Journal of General Virology 66:2297–2312
    [Google Scholar]
  26. Stauber E., Burger D., Piper R. 1975; The pathogenesis of lactate dehydrogenase elevating virus in mice. Journal of Comparative Pathology 85:171–183
    [Google Scholar]
  27. Weiland E., Thiel H.-J. 1985; Monoclonal antibody detects a common surface antigen on two independently established murine Moloney sarcoma virus non-producer transformants. Journal of General Virology 66:1863–1872
    [Google Scholar]
  28. Weiland E., Weiland F. 1985; Detection and preliminary characterization of a transmissible agent inducing autoantibody against Golgi-antigen. Clinical and Experimental Immunology 62:167–175
    [Google Scholar]
  29. Weiland E., Mussgay M., Weiland F. 1978; Non-producer malignant tumour cells with rescuable sarcoma virus genome isolated from a recurred Moloney sarcoma. Journal of Experimental Medicine 148:408–423
    [Google Scholar]
  30. Weiland E., Weiland F., Thiel H.-J. 1984; Autoantibody activity against evolutionary conserved, juxtanuclearly arranged antigen in mice with tumours induced by a progressor Moloney sarcoma virus transformant. Experimental Cell Biology 52:300–310
    [Google Scholar]
  31. Wolfgram L. J., Beisel K. W., Rose N. R. 1985; Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. Journal of Experimental Medicine 161:1112–1121
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-68-7-1983
Loading
/content/journal/jgv/10.1099/0022-1317-68-7-1983
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error